![]() |
市場調查報告書
商品編碼
1306526
動脈粥狀硬化斑塊切除術和血管內碎石(IVL)設備的全球市場:規模,佔有率,趨勢,COVID-19影響分析(2023年~2029年):MedCoreAtherectomy & Intravascular Lithotripsy (IVL) Devices Market Size, Share, Trends & COVID19 Impact Analysis | Global | 2023-2029 | MedCore | Includes: Laser Atherectomy, Mechanical Atherectomy and IVL Devices. |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
2022年,全球旋切術和血管內碎石機市場將達到8.01億美元。預計在預測期內復合年增長率為 6.1%,到 2029 年將超過 12 億美元。
本報告提供全球動脈粥狀硬化斑塊切除術與血管內碎石(IVL)設備市場相關調查,提供市場概要,以及各市場區隔,各地區趨勢,競爭情形等資訊。
In 2022, the global market for atherectomy and Intravascular Lithotripsy devices reached a valuation of more than $801 million. It is projected to grow at a compound annual growth rate (CAGR) of 6.1% during the forecast period, surpassing $1.2 billion.
The market includes laser atherectomy, mechanical atherectomy, and IVL devices, and it is analyzed as a single entity without further segmentation.
In our comprehensive study on the global atherectomy devices market, iData Research has conducted an in-depth analysis of atherectomy and Intravascular lithotripsy procedure volumes. This analysis aims to enhance the accuracy of our market sizing and provide you with valuable insights into the volume of procedures conducted over a 10-year period across 70 countries.
Coronary atherectomy procedures are typically conducted after the identification of artery calcification through an angioplasty or other diagnostic procedure. While coronary physicians may not consider atherectomy as their primary choice, the number of atherectomy procedures is anticipated to rise in conjunction with the increasing utilization of angioplasty procedures.
The market for coronary atherectomy is expected to be limited by the efficacy of drug-eluting stents (DESs). The use of DESs provides cardiologists with a sense of confidence in preventing restenosis, potentially leading them to be less cautious in preparing the lesion before stent deployment. As the utilization of DESs becomes more prevalent in coronary procedures, the demand for atherectomy devices is likely to decline.
The global market for atherectomy and intravascular lithotripsy devices in 2022 was dominated by three key competitors: ShockWave Medical, Boston Scientific, and Cardiovascular Systems, Inc.
ShockWave Medical, as the leading competitor, specializes in IVL technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases. Their device, ShockWave C2, has established a strong market presence.
Boston Scientific, the second-leading competitor, focuses on the mechanical atherectomy device market. While they continue to maintain competitiveness in this segment, they have experienced a decline in market share in recent years.
Cardiovascular Systems, Inc. (CSI) held the third-leading position in the coronary atherectomy device market. Their presence in the overall market was primarily attributed to their involvement in the mechanical atherectomy device segment, where they held a significant share.
Overall, these three competitors played a crucial role in shaping the atherectomy and IVL device market landscape in 2022.
Throughout our comprehensive research series, iData Research has extensively covered and analyzed over 70 countries worldwide. Each global region can be purchased as an individual report, allowing you to tailor the data specifically to your needs.